These scientists discovered that obese and lean PCOS patients have varied levels of miRNA enrichment in FF-EVs targeting important pathways, including p53, FOXO, Hippo, MAPK, JAK/STAT, and TNF signaling. This evidence concerns the gene TP53 and polycystic ovary syndrome.